
Stellantis to Keep Buying Tesla CO2 Credits Despite EU Compliance Delay
Mar 30, 2025 06:56 am UTC| Business
Stellantis (NYSE: STLA), Europes second-largest automaker, will continue purchasing carbon credits from a pool led by Tesla (NASDAQ: TSLA) in 2025 to meet the EUs CO2 emissions targets, even after the European Commission...

UBS Confirms Commitment to Switzerland Amid Regulatory Debate
Mar 29, 2025 07:05 am UTC| Business
UBS has reaffirmed its commitment to Switzerland, dispelling rumors about a potential exit due to rising regulatory pressure. Markus Ronner, the banks head of compliance and governance, stated on Friday that UBS certainly...

FBI Investigates Oracle Cyberattack Targeting Patient Data
Mar 29, 2025 07:05 am UTC| Business
The FBI is investigating a recent cyberattack on Oracle (NYSE:ORCL) that led to the theft of sensitive patient data, according to a Bloomberg report citing a source familiar with the matter. Oracle reportedly alerted some...

Panama Cancels Registrations of Over 100 Sanctioned Vessels
Mar 29, 2025 07:05 am UTC| Business Governance
Panamas Maritime Authority announced the cancellation of 107 ships from its registry after the vessels were found on international sanctions lists. The move comes as part of the countrys effort to maintain transparency and...

CoreWeave’s Nasdaq Debut Falls Flat Amid AI IPO Jitters
Mar 29, 2025 07:05 am UTC| Business
CoreWeave, the Nvidia-backed AI infrastructure firm, saw its shares open nearly 3% below the $40 IPO price and close flat on its Nasdaq debut, valuing the company at $23 billion on a fully diluted basis. Despite raising...

Elon Musk Faces Lawsuit Over Delayed Twitter Stake Disclosure
Mar 29, 2025 07:04 am UTC| Business Law
A U.S. judge has denied Elon Musks attempt to dismiss a lawsuit accusing him of defrauding former Twitter shareholders by delaying the disclosure of his investment in the social media platform, now known as X. U.S....

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing
Mar 29, 2025 07:04 am UTC| Business Science
The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...